Dysport vs. Botox: An Honest Comparison from an Asheville Injector
Everyone knows Botox. Far fewer patients know that Dysport — the neuromodulator medAge primarily uses — often produces faster onset and a more natural result for the right patient. Here’s the honest comparison.
The conversation in our consultation room happens regularly: a patient says they want “Botox,” and we explain that at medAge, our injectors primarily work with Dysport and Xeomin — both part of the Merz Aesthetics portfolio we partner with. The question that follows is almost always: “Is that as good as Botox?”
The honest answer is: for the right patient, it can be better. Here’s why.
All three are the same category of drug
Botox, Dysport, and Xeomin are all botulinum toxin type A. They all work by temporarily blocking the nerve signals that cause muscle contraction. The effect — softened wrinkles, preserved expression when done well — is the same category of outcome.
The differences are in formulation, dosing, onset speed, spread characteristics, and how different patients respond. None of them is universally superior. They’re tools, and good injectors match the tool to the patient and the treatment area.
Dysport vs. Botox: what actually differs
| Factor | Botox | Dysport |
|---|---|---|
| Onset | 3–5 days to initial effect; full result at 14 days | Often 2–3 days; many patients report faster visible results |
| Spread | More localized | Spreads slightly more — an advantage in larger areas like the forehead |
| Dosing | 1 unit = 1 unit (manufacturer units differ — not directly equivalent) | Dysport units are not interchangeable with Botox units; your injector adjusts accordingly |
| Duration | 3–4 months typically | 3–4 months; some patients report slightly longer duration with Dysport |
| Best for | Precise, targeted areas; patients with small treatment zones | Forehead, glabella, larger treatment areas; patients who have plateaued on Botox |
What about Xeomin?
Xeomin is a “naked” botulinum toxin — it lacks the accessory proteins found in Botox and Dysport. This makes it an excellent option for patients who’ve developed resistance to other neuromodulators, because there’s no protein component to generate antibodies against. It’s also FDA-approved and has a long clinical track record. At medAge, we use Xeomin for patients who need it — it’s not a backup, it’s a clinical choice.
Which one is right for you?
If you’ve been happy with Botox results elsewhere and are simply new to medAge — great, we can discuss your treatment history and preferences. If you’ve experienced diminishing returns, or want a faster onset, or have a larger treatment area — Dysport may be the more effective option.
The only thing we won’t do is make the choice without talking to you first. Neuromodulator treatment at medAge starts with a conversation about your goals, your anatomy, and your history. That conversation shapes everything.
Ready to discuss which neuromodulator is right for your face? Our injectors will give you a straight answer.
